Cytoreduction with Hyperthermic Intraperitoneal Chemotherapy and Renal Insufficiency Related to Diabetes Mellitus: An Anesthetic Challenge

1. Esquivel J, Sticca R, Sugarbaker P, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surg Oncol. 2007;14:128-133.10.1245/s10434-006-9185-717072675Open DOISearch in Google Scholar

2. Randle RW, Ahmed S, Levine EA, et al. Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2015;111:740-745.10.1002/jso.23865440679725556634Search in Google Scholar

3. Glehen O, Osinsky D, Cotte E, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol. 2003;10:863-869.10.1245/ASO.2003.01.018Search in Google Scholar

4. Verwaal VJ, van Tinteren H, Ruth SV, Zoetmulder FA. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol. 2004; 85: 61-67.10.1002/jso.2001314755505Open DOISearch in Google Scholar

5. Kusamura S, Baratti D, Younan R, et al. Impact of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy on systemic toxicity. Ann Surg Oncol. 2007;14:2550-2558.10.1245/s10434-007-9429-117558537Open DOISearch in Google Scholar

6. Cotte E, Passot G, Gilly FN, Glehen O. Selection of patients and staging of peritoneal surface malignancies. World J Gastrointest Oncol. 2010;2:31-35.10.4251/wjgo.v2.i1.31299915821160814Search in Google Scholar

7. Ulusakarya A, Misra S, Haydar M, et al. Acute renal failure related to oxaliplatin-induced intravascular hemolysis. Med Oncol. 2010;27:1425-1426.10.1007/s12032-009-9263-319565364Open DOISearch in Google Scholar

8. Puiac C, Szederjesi J, Lazar A, Bad C, Puscasiu L. Neutrophil Gelatinase-Associated Lipocalin as a Marker for Renal Dysfunction Detection in Critically Ill Patients with Increased Intraabdominal Pressure. J Crit Care Med. 2017;3(1):24-28.10.1515/jccm-2017-0006576989529967867Search in Google Scholar

9. Corbella D, Piraccini E, Finazzi P, et al. Anesthetic management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy procedures. World J Obstet Gynecol. 2013;2:129-13610.5317/wjog.v2.i4.129Open DOISearch in Google Scholar

10. Esquivel J, Angulo F, Bland RK, Stephens AD, Sugarbaker PH. Hemodynamic and cardiac function parameters during heated intraoperative intraperitoneal chemotherapy using the open “coliseum technique”. Ann Surg Oncol. 2000;7:296-300.10.1007/s10434-000-0296-210819370Search in Google Scholar

11. Christophi C, Winkworth A, Muralihdaran V, Evans P. The treatment of malignancy by hyperthermia. Surg Oncol. 1998;7:83-90.10.1016/S0960-7404(99)00007-9Open DOISearch in Google Scholar

12. Miao N, Pingpank JF, Alexander HR, et al. Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerations. Ann Surg Oncol. 2009;16:334-344.10.1245/s10434-008-0253-z263746819050961Open DOISearch in Google Scholar

13. Raue W, Tsilimparis N, Bloch A, Menenakos C, Hartmann J. Volume therapy and cardiocircular function during hyperthermic intraperitoneal chemotherapy. Eur Surg Res. 2009;43:365-372.10.1159/00024816419844110Search in Google Scholar

14. Cafiero T, Di Iorio C, Di Minno RM, Sivolella G, Confuorto G. Non-invasive cardiac monitoring by aortic blood flow determination in patients undergoing hyperthermic intraperitoneal intraoperative chemotherapy. Minerva Anestesiol. 2006;72:207-215.Search in Google Scholar